A study says ribociclib, a drug approved for treating advanced-stage breast cancer, may help reduce the risk of recurrence in women who have been treated for certain types of early-stage breast cancer. Research is ongoing.
Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.
